Neoleukin Therapeutics Inc Stock News

Brasil chega a 100 mil mortos e a batalha contra a doença ainda é uma realidade feminina

* NL-201 IND submission anticipated during fourth quarter of 2020 * Recent financing raises $71.4M in net proceeds to enable broad NL-201 clinical plan and product pipeline development into 2023 * C

In our latest UK Leaders article, Novo Nordisk’s UK general manager Pinder Sahota tells us how he hopes to bring the NHS and pharma together to improve outcomes in diabetes and other long-term condi

A new international survey of those with eating disorders found that symptoms were worsening, even in those who had previously been stable and in remission, over Covid-19.

Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...

Aug. 9 1916 — The Philadelphia A’s ended their 20-game losing streak as Joe Bush beat the Detroit Tigers 7-1. 1939 — Red Rolfe of the New York Yankees started a streak of 18...

Utrecht University and Bruker Announce Collaboration to Develop Methods for Studying Protein Structures and Interactions by Mass Spectrometry

Aug. 9 1916 — The Philadelphia A’s ended their 20-game losing streak as Joe Bush beat the Detroit Tigers 7-1. 1939 — Red Rolfe of the New York Yankees started a streak of 18...

SEATTLE, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo pr

Denmark’s Novo Nordisk has beaten profit forecasts in the second quarter after overcoming tough conditions in the diabetes market by improving its productivity.